Back to search
FDAFDA · Food and drugs·Recall number D-1740-2015

PGE 2 (Alprostadil) 100 mcg/ml, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN

Published September 23, 2015 · Recall initiated: June 2, 2015

Summary

FDA records drug Class II recall D-1740-2015, published September 23, 2015 and initiated June 2, 2015. Recalling firm: The Compounding Pharmacy of America; Status: Terminated; Reported quantity: 25 ml; Lot: All lots distributed between November 2014 and May 2015; 04282015@46, 10/25/2015; 04302015@31, 10/27/2015; 05072015@36, 11/3/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
The Compounding Pharmacy of America
Distributor
Nationwide
Lot
All lots distributed between November 2014 and May 2015; 04282015@46, 10/25/2015; 04302015@31, 10/27/2015; 05072015@36, 11/3/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PGE 2 (Alprostadil) 100 mcg/ml, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN recalled?

Yes. FDA published recall D-1740-2015 on September 23, 2015. Reported hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

What should I do if I have this product?

Voluntary: Firm initiated · Telephone